Effect of Comorbidity on Outcomes of Patients with Advanced Non-Small Cell Lung Cancer Undergoing Anti-PD1 Immunotherapy

BACKGROUND: Comorbidities are reportedly related to the survival of patients with non-small cell lung cancer (NSCLC). The purpose of this study was to explore the impact of comorbidity, assessed by the Charlson comorbidity index (CCI) and the simplified comorbidity scores (SCS) on clinical outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Xianghua, Zhu, Shicong, Xu, Cheng, Wang, Zhongyu, Su, Xingxing, Zeng, Dong, Long, Haixia, Zhu, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2020
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496511/
https://www.ncbi.nlm.nih.gov/pubmed/32893263
http://dx.doi.org/10.12659/MSM.922576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496511/
https://www.ncbi.nlm.nih.gov/pubmed/32893263
http://dx.doi.org/10.12659/MSM.922576

Ejemplares similares